1. Home
  2. CMPX vs LMNR Comparison

CMPX vs LMNR Comparison

Compare CMPX & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • LMNR
  • Stock Information
  • Founded
  • CMPX 2014
  • LMNR 1893
  • Country
  • CMPX United States
  • LMNR United States
  • Employees
  • CMPX N/A
  • LMNR N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • LMNR Farming/Seeds/Milling
  • Sector
  • CMPX Health Care
  • LMNR Consumer Staples
  • Exchange
  • CMPX Nasdaq
  • LMNR Nasdaq
  • Market Cap
  • CMPX 291.8M
  • LMNR 292.4M
  • IPO Year
  • CMPX N/A
  • LMNR N/A
  • Fundamental
  • Price
  • CMPX $3.51
  • LMNR $15.00
  • Analyst Decision
  • CMPX Strong Buy
  • LMNR Buy
  • Analyst Count
  • CMPX 8
  • LMNR 2
  • Target Price
  • CMPX $13.50
  • LMNR $20.50
  • AVG Volume (30 Days)
  • CMPX 876.2K
  • LMNR 51.6K
  • Earning Date
  • CMPX 11-11-2025
  • LMNR 09-09-2025
  • Dividend Yield
  • CMPX N/A
  • LMNR 1.98%
  • EPS Growth
  • CMPX N/A
  • LMNR N/A
  • EPS
  • CMPX N/A
  • LMNR N/A
  • Revenue
  • CMPX N/A
  • LMNR $160,763,000.00
  • Revenue This Year
  • CMPX N/A
  • LMNR N/A
  • Revenue Next Year
  • CMPX N/A
  • LMNR N/A
  • P/E Ratio
  • CMPX N/A
  • LMNR N/A
  • Revenue Growth
  • CMPX N/A
  • LMNR N/A
  • 52 Week Low
  • CMPX $1.27
  • LMNR $14.40
  • 52 Week High
  • CMPX $4.08
  • LMNR $29.22
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 59.49
  • LMNR 41.15
  • Support Level
  • CMPX $3.37
  • LMNR $14.70
  • Resistance Level
  • CMPX $3.77
  • LMNR $15.55
  • Average True Range (ATR)
  • CMPX 0.19
  • LMNR 0.39
  • MACD
  • CMPX 0.01
  • LMNR -0.10
  • Stochastic Oscillator
  • CMPX 46.87
  • LMNR 17.24

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

Share on Social Networks: